{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:24:47Z","timestamp":1790789087014,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The efficacy of highly restrictive dietary therapies such as exclusive enteral nutrition (EEN) in the induction of remission in Crohn\u2019s disease (CD) are well established, however, ongoing issues exist with its poor palatability, restrictions, and adherence. The primary aim of this review is to evaluate the current evidence for the efficacy of exclusively solid food diets on the induction and maintenance of clinical and biochemical remission in CD. Secondary aims include impact on endoscopic healing and quality of life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review of all randomised controlled trials (RCTs), open-label randomised trials and head-to-head clinical trials assessing solid food diet intervention in patients with active or inactive Crohn\u2019s disease was conducted. Studies included adult and paediatric patients with a verified disease activity index at baseline and follow up (Harvey Bradshaw Index, HBI; Crohn\u2019s disease activity index, CDAI and paediatric CDAI, PCDAI). Additional secondary endpoints varied between studies, including endoscopic and biochemical responses, as well as quality of life measures. Two authors independently performed critical appraisals of the studies, including study selection and risk of bias assessments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>14 studies were included for review, with several studies suggesting clinically significant findings. Clinical remission was achieved in a paediatric population undertaking the Mediterranean diet (MD) (moderate risk of bias). In adults, the Crohn\u2019s disease exclusion diet (CDED) was comparable to the CDED with partial enteral nutrition (PEN) diet in induction of remission (moderate risk of bias). A low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet was also shown to decrease symptoms in patients with quiescent or mildly active CD (high risk of bias), however, this was not corroborated by other low FODMAP diet studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>There are promising outcomes for the MD and CDED in inducing clinical remission in mild to moderate CD. The results need to be interpreted with caution due to design limitations, including issues with combining outcomes among CD and UC patients, and small sample size. The current evidence for solid food dietary therapy in CD is limited by the lack of high quality studies and moderate to high bias. Future well designed studies are needed to confirm their efficacy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12876-024-03315-7","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T06:02:21Z","timestamp":1722924141000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The effect of solid food diet therapies on the induction and maintenance of remission in Crohn\u2019s disease: a systematic review"],"prefix":"10.1186","volume":"24","author":[{"given":"Jennifer Li","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikil","family":"Vootukuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Niewiadomski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,6]]},"reference":[{"issue":"2","key":"3315_CR1","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/ng.3760","volume":"49","author":"KM de Lange","year":"2017","unstructured":"de Lange KM, Moutsianas L, Lee JC, Lamb CA, Luo Y, Kennedy NA, et al. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. Nat Genet. 2017;49(2):256\u201361.","journal-title":"Nat Genet"},{"issue":"6","key":"3315_CR2","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1136\/gutjnl-2020-321798","volume":"70","author":"M Agrawal","year":"2021","unstructured":"Agrawal M, Corn G, Shrestha S, Nielsen NM, Frisch M, Colombel JF, et al. Inflammatory bowel diseases among first-generation and second-generation immigrants in Denmark: a population-based cohort study. Gut. 2021;70(6):1037\u201343.","journal-title":"Gut"},{"issue":"5","key":"3315_CR3","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1136\/gut.40.5.572","volume":"40","author":"J Satsangi","year":"1997","unstructured":"Satsangi J, Jewell DP, Bell JI. The genetics of inflammatory bowel disease. Gut. 1997;40(5):572\u20134.","journal-title":"Gut"},{"issue":"27","key":"3315_CR4","doi-asserted-by":"publisher","first-page":"6296","DOI":"10.3748\/wjg.v22.i27.6296","volume":"22","author":"AT Abegunde","year":"2016","unstructured":"Abegunde AT, Muhammad BH, Bhatti O, Ali T. Environmental risk factors for inflammatory bowel diseases: evidence based literature review. World J Gastroenterol. 2016;22(27):6296\u2013317.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"3315_CR5","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/ajg.2011.44","volume":"106","author":"JK Hou","year":"2011","unstructured":"Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol. 2011;106(4):563\u201373.","journal-title":"Am J Gastroenterol"},{"key":"3315_CR6","unstructured":"Limketkai BN, Godoy-Brewer G, Parian AM, Noorian S, Krishna M, Shah ND et al. Dietary interventions for the treatment of Inflammatory Bowel diseases: an updated systematic review and Meta-analysis. Clin Gastroenterol Hepatol. 2022."},{"issue":"4","key":"3315_CR7","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1053\/j.gastro.2014.06.024","volume":"147","author":"A Lahiri","year":"2014","unstructured":"Lahiri A, Abraham C. Activation of pattern recognition receptors up-regulates metallothioneins, thereby increasing intracellular accumulation of zinc, autophagy, and bacterial clearance by macrophages. Gastroenterology. 2014;147(4):835\u201346.","journal-title":"Gastroenterology"},{"issue":"1","key":"3315_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/jgh.13050","volume":"31","author":"C Studd","year":"2016","unstructured":"Studd C, Cameron G, Beswick L, Knight R, Hair C, McNeil J, et al. Never underestimate inflammatory bowel disease: high prevalence rates and confirmation of high incidence rates in Australia. J Gastroenterol Hepatol. 2016;31(1):81\u20136.","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"3315_CR9","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1136\/gut.2010.224154","volume":"60","author":"C Mowat","year":"2011","unstructured":"Mowat C, Cole A, Windsor A, Ahmad T, Arnott I, Driscoll R, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2011;60(5):571\u2013607.","journal-title":"Gut"},{"issue":"2","key":"3315_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.clnu.2016.12.027","volume":"36","author":"A Forbes","year":"2017","unstructured":"Forbes A, Escher J, H\u00e9buterne X, K\u0142\u0119k S, Krznaric Z, Schneider S, et al. ESPEN guideline: clinical nutrition in inflammatory bowel disease. Clin Nutr. 2017;36(2):321\u201347.","journal-title":"Clin Nutr"},{"key":"3315_CR11","doi-asserted-by":"crossref","unstructured":"van Rheenen PF, Aloi M, Assa A, Bronsky J, Escher JC, Fagerberg UL et al. The Medical Management of Paediatric Crohn\u2019s Disease: an ECCO-ESPGHAN Guideline Update. J Crohns Colitis. 2020.","DOI":"10.1093\/ecco-jcc\/jjaa161"},{"issue":"43","key":"3315_CR12","doi-asserted-by":"publisher","first-page":"7652","DOI":"10.3748\/wjg.v19.i43.7652","volume":"19","author":"CL Wall","year":"2013","unstructured":"Wall CL, Day AS, Gearry RB. Use of exclusive enteral nutrition in adults with Crohn\u2019s disease: a review. World J Gastroenterol. 2013;19(43):7652\u201360.","journal-title":"World J Gastroenterol"},{"key":"3315_CR13","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Torres L, Moreno-\u00c1lvarez A, Fern\u00e1ndez-Lorenzo AE, Leis R, Solar-Boga A. The Role of Partial Enteral Nutrition for Induction of Remission in Crohn\u2019s Disease: A Systematic Review of Controlled Trials. Nutrients. 2022;14(24).","DOI":"10.3390\/nu14245263"},{"key":"3315_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.nutres.2020.06.006","volume":"81","author":"H Yang","year":"2020","unstructured":"Yang H, Feng R, Li T, Xu S, Hao X, Qiu Y, et al. Systematic review with meta-analysis of partial enteral nutrition for the maintenance of remission in Crohn\u2019s disease. Nutr Res. 2020;81:7\u201318.","journal-title":"Nutr Res"},{"issue":"2","key":"3315_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000494022","volume":"37","author":"JHM de Vries","year":"2019","unstructured":"de Vries JHM, Dijkhuizen M, Tap P, Witteman BJM. Patient\u2019s Dietary beliefs and behaviours in Inflammatory Bowel Disease. Dig Dis. 2019;37(2):131\u20139.","journal-title":"Dig Dis"},{"key":"3315_CR16","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.2147\/JIR.S349502","volume":"15","author":"D El Amrousy","year":"2022","unstructured":"El Amrousy D, Elashry H, Salamah A, Maher S, Abd-Elsalam SM, Hasan S. Adherence to the Mediterranean Diet Improved Clinical scores and inflammatory markers in children with active inflammatory bowel disease: a Randomized Trial. J Inflamm Res. 2022;15:2075\u201386.","journal-title":"J Inflamm Res"},{"key":"3315_CR17","doi-asserted-by":"publisher","first-page":"110542","DOI":"10.1016\/j.nut.2019.06.023","volume":"67","author":"G Bodini","year":"2019","unstructured":"Bodini G, Zanella C, Crespi M, Lo Pumo S, Demarzo MG, Savarino E, et al. A randomized, 6-wk trial of a low FODMAP diet in patients with inflammatory bowel disease. Nutrition. 2019;67:110542.","journal-title":"Nutrition"},{"issue":"1","key":"3315_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S2468-1253(21)00299-5","volume":"7","author":"H Yanai","year":"2022","unstructured":"Yanai H, Levine A, Hirsch A, Boneh RS, Kopylov U, Eran HB, et al. The Crohn\u2019s disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn\u2019s disease (CDED-AD): an open-label, pilot, randomised trial. Lancet Gastroenterol Hepatol. 2022;7(1):49\u201359.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"3315_CR19","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.cgh.2020.01.046","volume":"18","author":"A Levine","year":"2020","unstructured":"Levine A, Rhodes JM, Lindsay JO, Abreu MT, Kamm MA, Gibson PR, et al. Dietary Guidance from the International Organization for the study of Inflammatory Bowel diseases. Clin Gastroenterol Hepatol. 2020;18(6):1381\u201392.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3315_CR20","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JACSJ Sterne","year":"2019","unstructured":"Sterne JACSJ, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"key":"3315_CR21","doi-asserted-by":"crossref","unstructured":"Cox S, Lindsay J, Fromentin S, Stagg A, McCarthy N, Galleron N et al. Effects of Low FODMAP Diet on symptoms, fecal microbiome, and markers of inflammation in patients with quiescent inflammatory bowel disease in a Randomized Trial. 2020;158(1):176\u2013e887.","DOI":"10.1053\/j.gastro.2019.09.024"},{"issue":"6597","key":"3315_CR22","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1136\/bmj.295.6597.517","volume":"295","author":"JK Ritchie","year":"1987","unstructured":"Ritchie JK, Wadsworth J, Lennard-Jones JE, Rogers E. Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn\u2019s disease. Br Med J (Clin Res Ed). 1987;295(6597):517\u201320.","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"18","key":"3315_CR23","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.3748\/wjg.v23.i18.3356","volume":"23","author":"N Pedersen","year":"2017","unstructured":"Pedersen N, Ankersen DV, Felding M, Wachmann H, V\u00e9gh Z, Molzen L, et al. Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease. World J Gastroenterol. 2017;23(18):3356\u201366.","journal-title":"World J Gastroenterol"},{"key":"3315_CR24","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1093\/ibd\/izy019.003","volume":"24","author":"L Albenberg","year":"2018","unstructured":"Albenberg L, Brensinger C, Wu Q, Gilroy E, Kappelman M, Sandler R, et al. A diet low in red and processed meats does not reduce the rate of Crohn\u2019s disease flares in a randomized controlled trial: results of the food and Crohn\u2019s disease exacerbation study (faces). Inflamm Bowel Dis. 2018;24:S2\u20133.","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"3315_CR25","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3109\/00365529609010352","volume":"31","author":"H Lorenz-Meyer","year":"1996","unstructured":"Lorenz-Meyer H, Bauer P, Nicolay C, Schulz B, Purrmann J, Fleig WE, et al. Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn\u2019s disease. A randomized controlled multicenter trial. Study Group members (German Crohn\u2019s Disease Study Group). Scand J Gastroenterol. 1996;31(8):778\u201385.","journal-title":"Scand J Gastroenterol"},{"issue":"6193","key":"3315_CR26","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1136\/bmj.2.6193.764","volume":"2","author":"KW Heaton","year":"1979","unstructured":"Heaton KW, Thornton JR, Emmett PM. Treatment of Crohn\u2019s disease with an unrefined-carbohydrate, fibre-rich diet. Br Med J. 1979;2(6193):764\u20136.","journal-title":"Br Med J"},{"issue":"12","key":"3315_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu12123749","volume":"12","author":"DL Suskind","year":"2020","unstructured":"Suskind DL, Lee D, Kim Y-M, Wahbeh G, Singh N, Braly K, et al. The specific carbohydrate diet and diet modification as induction therapy for pediatric crohn\u2019s disease: a randomized diet controlled trial. Nutrients. 2020;12(12):1\u201323.","journal-title":"Nutrients"},{"issue":"4","key":"3315_CR28","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1007\/s10620-015-3987-z","volume":"61","author":"V Gunasekeera","year":"2016","unstructured":"Gunasekeera V, Mendall MA, Chan D, Kumar D. Treatment of Crohn\u2019s Disease with an IgG4-Guided Exclusion Diet: a Randomized Controlled Trial. Dig Dis Sci. 2016;61(4):1148\u201357.","journal-title":"Dig Dis Sci"},{"issue":"10","key":"3315_CR29","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1136\/gut.26.10.989","volume":"26","author":"S Levenstein","year":"1985","unstructured":"Levenstein S, Prantera C, Luzi C, D\u2019Ubaldi A. Low residue or normal diet in Crohn\u2019s disease: a prospective controlled study in Italian patients. Gut. 1985;26(10):989\u201393.","journal-title":"Gut"},{"issue":"3","key":"3315_CR30","first-page":"374","volume":"14","author":"G Bartel","year":"2008","unstructured":"Bartel G, Weiss I, Turetschek K, Schima W, P\u00fcsp\u00f6k A, Waldhoer T, et al. Ingested Matter Affects Intestinal Lesions Crohn\u2019s Disease. 2008;14(3):374\u201382.","journal-title":"Ingested Matter Affects Intestinal Lesions Crohn\u2019s Disease"},{"issue":"2","key":"3315_CR31","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1053\/j.gastro.2019.04.021","volume":"157","author":"A Levine","year":"2019","unstructured":"Levine A, Wine E, Assa A, Sigall Boneh R, Shaoul R, Kori M, et al. Crohn\u2019s Disease Exclusion Diet Plus partial Enteral Nutrition induces sustained remission in a Randomized Controlled Trial. Gastroenterology. 2019;157(2):440\u2013. \u2013\u200950.e8.","journal-title":"Gastroenterology"},{"key":"3315_CR32","unstructured":"Lewis JD, Sandler R, Brotherton C, Brensinger C, Li H, Kappelman MD et al. A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults with Crohn\u2019s Disease. Gastroenterology. 2021."},{"key":"3315_CR33","doi-asserted-by":"crossref","unstructured":"Brotherton C, Taylor A, Bourguignon C, Anderson J. A high-fiber diet may improve bowel function and health-related quality of life in patients with Crohn disease. 2014;37(3):206\u201316.","DOI":"10.1097\/SGA.0000000000000047"},{"issue":"6","key":"3315_CR34","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1136\/gutjnl-2021-325214","volume":"71","author":"CJ Black","year":"2022","unstructured":"Black CJ, Staudacher HM, Ford AC. Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis. Gut. 2022;71(6):1117\u201326.","journal-title":"Gut"},{"key":"3315_CR35","doi-asserted-by":"crossref","unstructured":"Popa SL, Pop C, Dumitrascu DL. Diet Advice for Crohn\u2019s Disease: FODMAP and Beyond. Nutrients. 2020;12(12).","DOI":"10.3390\/nu12123751"},{"issue":"5","key":"3315_CR36","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1053\/j.gastro.2018.12.002","volume":"156","author":"V Svolos","year":"2019","unstructured":"Svolos V, Hansen R, Nichols B, Quince C, Ijaz UZ, Papadopoulou RT, et al. Treatment of active Crohn\u2019s Disease with an ordinary food-based Diet that replicates exclusive Enteral Nutrition. Gastroenterology. 2019;156(5):1354\u2013e676.","journal-title":"Gastroenterology"},{"issue":"11\u201312","key":"3315_CR37","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/apt.14351","volume":"46","author":"M Logan","year":"2017","unstructured":"Logan M, Ijaz UZ, Hansen R, Gerasimidis K, Russell RK. Letter: reproducible evidence shows that exclusive enteral nutrition significantly reduces faecal calprotectin concentrations in children with active Crohn\u2019s disease. Aliment Pharmacol Ther. 2017;46(11\u201312):1119\u201320.","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"3315_CR38","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.crohns.2014.04.005","volume":"8","author":"FM Ruemmele","year":"2014","unstructured":"Ruemmele FM, Veres G, Kolho KL, Griffiths A, Levine A, Escher JC, et al. Consensus guidelines of ECCO\/ESPGHAN on the medical management of pediatric Crohn\u2019s disease. J Crohns Colitis. 2014;8(10):1179\u2013207.","journal-title":"J Crohns Colitis"},{"issue":"4","key":"3315_CR39","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1159\/000264649","volume":"81","author":"S Bentz","year":"2010","unstructured":"Bentz S, Hausmann M, Piberger H, Kellermeier S, Paul S, Held L, et al. Clinical relevance of IgG antibodies against food antigens in Crohn\u2019s disease: a double-blind cross-over diet intervention study. Digestion. 2010;81(4):252\u201364.","journal-title":"Digestion"},{"issue":"4","key":"3315_CR40","first-page":"423","volume":"36","author":"RC Chase","year":"2023","unstructured":"Chase RC, Tamim H, Sheikh WGE, Clift K, Bruining D, Ha C, et al. Association of serum IgG4 and disease outcomes in patients with inflammatory bowel disease. Ann Gastroenterol. 2023;36(4):423\u20139.","journal-title":"Ann Gastroenterol"},{"issue":"7","key":"3315_CR41","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/j.1398-9995.2008.01705.x","volume":"63","author":"SO Stapel","year":"2008","unstructured":"Stapel SO, Asero R, Ballmer-Weber BK, Knol EF, Strobel S, Vieths S, et al. Testing for IgG4 against foods is not recommended as a diagnostic tool: EAACI Task Force Report. Allergy. 2008;63(7):793\u20136.","journal-title":"Allergy"},{"issue":"9","key":"3315_CR42","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1136\/gutjnl-2017-315866","volume":"67","author":"A Levine","year":"2018","unstructured":"Levine A, Sigall Boneh R, Wine E. Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases. Gut. 2018;67(9):1726\u201338.","journal-title":"Gut"},{"issue":"7","key":"3315_CR43","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1136\/gutjnl-2020-322670","volume":"70","author":"LA Bolte","year":"2021","unstructured":"Bolte LA, Vich Vila A, Imhann F, Collij V, Gacesa R, Peters V, et al. Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome. Gut. 2021;70(7):1287\u201398.","journal-title":"Gut"},{"issue":"6","key":"3315_CR44","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/advances\/nmz022","volume":"10","author":"RL Hughes","year":"2019","unstructured":"Hughes RL, Marco ML, Hughes JP, Keim NL, Kable ME. The role of the gut Microbiome in Predicting Response to Diet and the development of Precision Nutrition Models\u2014Part I: overview of current methods. Adv Nutr. 2019;10(6):953\u201378.","journal-title":"Adv Nutr"},{"issue":"8","key":"3315_CR45","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1136\/gutjnl-2016-313099","volume":"66","author":"B Chassaing","year":"2017","unstructured":"Chassaing B, Van de Wiele T, De Bodt J, Marzorati M, Gewirtz AT. Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation. Gut. 2017;66(8):1414\u201327.","journal-title":"Gut"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03315-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-024-03315-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03315-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T06:03:58Z","timestamp":1722924238000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-024-03315-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3315"],"URL":"https:\/\/doi.org\/10.1186\/s12876-024-03315-7","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,6]]},"assertion":[{"value":"12 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"250"}}